Anti-amyloidogenic, anti-oxidant and anti-apoptotic role of gelsolin in Alzheimer’s disease
- 284 Downloads
Fibrillar amyloid beta-protein (Aβ) is a major component of amyloid plaques in the brains of individuals with Alzheimer’s disease (AD) and of adults with Down syndrome (DS). Gelsolin, a cytoskeletal protein, is present both intracellularly (cytoplasmic form) and extracellularly (secretory form in biological fluids). These two forms of gelsolin differ from each other in length and in cysteinyl thiol groups. Previous studies from our and other groups have identified the anti-amyloidogenic role of gelsolin in AD. Our studies showed that both plasma and cytosolic gelsolin bind to Aβ, and that gelsolin inhibits the fibrillization of Aβ and solubilizes preformed fibrils of Aβ. Other studies have shown that peripheral administration of plasma gelsolin or transgene expression of plasma gelsolin can reduce amyloid load in the transgenic mouse model of AD. Our recent studies showed that gelsolin expression increases in cells in response to oxidative stress. Oxidative damage is considered a major feature in the pathophysiology of AD. Aβ not only can induce oxidative stress, but also its generation is increased as a result of oxidative stress. In this article, we review evidence of gelsolin as an anti-amyloidogenic agent that can reduce amyloid load by acting as an inhibitor of Aβ fibrillization, and as an antioxidant and anti-apoptotic protein.
KeywordsAlzheimer’s disease Amyloid beta-protein Apoptosis Gelsolin Oxidative stress
This work was supported in part by the funds from the New York State Office of Mental Retardation and Developmental Disabilities, and by NIH Grant No. AG020992.
- Bandopadhyay U, Dipak D, Banerjee RK (1999) Reactive oxygen species: oxidative damage and pathogenesis. Curr Sci 77:658–666Google Scholar
- Chauhan A, Chauhan VPS, Wegiel J et al (1996a) Impact of normal and heat-inactivated serum on in-vitro aggregation and fibrillization of synthetic amyloid beta-protein. Alzheimer’s Res 2:243–248Google Scholar
- Janmay PA (1994) Phosphoinositides and calcium as regulators of cellular actin assembly and disassembly. Annu Rev Physiol 56:169–191Google Scholar
- Koudinov A, Matsubara E, Frangione B et al (1994) The soluble form of Alzheimer’s amyloid beta-protein is complexed to high-density lipoprotein 3 and very high density lipoprotein in normal human plasma. Biochem Biophys Res Commun 205:1164–1171. doi: 10.1006/bbrc.1994.2788 PubMedCrossRefGoogle Scholar
- Paunio T, Kiuru S, Karonen S et al (1994) Quantification of gelsolin in the serum of familial amyloidosis, Finnish type (Agel). Amyloid Int J Exp Clin Invest 1:80–89Google Scholar
- Stossel TP (1990) Actin-membrane interactions in eukaryotic mammalian cells. In: Hoffman JF, Giebisch G (eds) Current topics in membranes and transport, vol 36. Academic Press, NY, pp 97–107Google Scholar
- Sultana R, Ravagna A, Mohmmad-Abdul H et al (2005) Ferulic acid ethyl ester protects neurons against amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J Neurochem 92:749–758. doi: 10.1111/j.1471-4159.2004.02899.x PubMedCrossRefGoogle Scholar
- Yu C, Kim SH, Ikeuchi T et al (2001) Characterization of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment gamma. Evidence for distinct mechanisms involved in gamma-secretase processing of the APP and Notch1 transmembrane domains. J Biol Chem 276:43756–43760. doi: 10.1074/jbc.C100410200 PubMedCrossRefGoogle Scholar